期刊文献+

高效液相色谱法测定非布司他原料药的含量

Determination of the content of febuxostat by high performance liquid chromatography
下载PDF
导出
摘要 目的:建立HPLC测定非布司他原料含量的方法。方法:以十八烷基硅烷键合硅胶为填充剂;以0.01mol/L醋酸钠溶液(用磷酸调节pH值至3.0)-乙腈(45∶55)为流动相;检测波长为313nm。结果:在浓度40~60μg/mL)(r=0.9999)范围内,峰面积与浓度呈良好的线性关系,加样回收率99.59%,RSD=0.34%(n=9)。结论:HPLC测定非布司他原料药的含量是可行的、准确的,重现性好,可作为非布司他原料药的含量测定方法。 Objective:To establish the HPLC method for determining the content of Febuxostat.Methods:Octadecylsilane-bonded silica gel was used as the filler;0.01mol/L sodium acetate solution (adjusting pH to 3.0with Phosphoric acid)-acetonitrile(45:55)was used as the mobile phase;detection wavelength was 313nm.Results:In the range of injection volume 40-60μg/mL (r=0.9999),There was a good linear relationship between the peak area and the injection volume.The recovery rate of the sample was 99.59%.and the RSD was 0.34%(n=9).Conclusion:The HPLC determination of Febuxostat raw material content is feasible,accurate,and good reproducibility, can be used as a method for determining the content of Febuxostat raw materials.
作者 杨谣谣 潘海群 禹玉洪 Yang Yaoyao;Pan Haiqun;Yu Yuhong(Department of Pharmacy,School of Pharmacy,Shanxi Medical University,Taiyuan 030001;Beijing Xinkaiyuan Pharmaceutical Technology Co.,Ltd.,Beijing 101100)
出处 《北方药学》 2019年第1期1-3,共3页 Journal of North Pharmacy
关键词 HPLC 非布司他原料药 含量测定 HPLC Febuxostat raw material Determination of content
  • 相关文献

参考文献3

二级参考文献53

  • 1MASSEY V, KOMAI H, PALMERr G, et al. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[ 3,4-d ] pyrimidines [ J ]. J Biol Chem, 1970, 245 ( 11 ) :2837 - 2844.
  • 2HORIUCHI H, OTA M, NISHIMURA S, et al. Allopurinol induces renal toxicity by impairing pyrimidine[J]. Life Sci, 2000, 66(21) :2051 -2070.
  • 3TAKANOB Y, HASE-AOKI K, HORIUCHI H, et al. Selectivity of febuxostat, a novel non-purine inhibitor of xanthlne oxidase/ xanthine dehydrogenase [ J ]. Life Sci, 2005, 76 (16) : 1835 - 1847.
  • 4OSADA Y, TSUCHIMOTO M, FUKUSHIMA H, et al. Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents[J]. Eur J Pharmacol, 1993, 241(2-3) :183-188.
  • 5HORIUCHI H, OTA M, KOBAYASHI M, et al. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats[ J]. Res Commun Mol Pathol Pharmacol, 1999, 104 ( 3 ) :307 - 319.
  • 6KOMORIYA K, OSADA Y, HASEGAWA M, et al. Hypouricemic effect of allopurinol and the novel xanthine oxldase inhibitor TE145720 in chimpanzees [ J ]. Eur J Pharmacol, 1993, 250 (3) :455 -460.
  • 7GRABOWSKI BA, VERNILLET L, KHOSRAVAN R, et al. Metabolism and excretion of [ ^14C ] febuxostat, a novel non-purine selective inhibitor of xanthine oxidase, in healthy male subjects [ J ]. Drug Metab Rev, 2005, 37 ( Suppl 2) : S111.
  • 8KHOSRAVAN R, KUKULKA M, WU JT, et al. The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase[J]. J Clin Pharmacol, 2008, 48 : 1014 - 1025.
  • 9KHOSRAVAN R, GRABOWSKI BA. , WU JT, et al. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects [ J ]. Clin Pharmacokinet, 2006, 45 (8) :821 -841.
  • 10KHOSRAVAN R, GRABOWSKI, B, WU JT, et al. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects[ J]. Br J Clin Pharmacol, 2008, 65 (3) :355 -363.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部